Psoriatic Arthritis
Conference Coverage
Clinicians still seek the best uses for apremilast
WAILEA, HAWAII – An expert calls apremilast outmatched for moderate to severe disease, but off-label use for moderate disease and other...
Conference Coverage
Adalimumab for psoriasis: Blocking TNF-alpha had no effect on vascular inflammation
A study evaluating the effects of blocking TNF-alpha on vascular inflammation in adults with psoriasis raises more questions than answers.
Conference Coverage
Dactylitis signals more severe psoriatic arthritis
SNOWMASS, COLO. – Studies of dactylitis and enthesitis – two commonly misdiagnosed extra-articular manifestations of psoriatic arthritis – are...
Conference Coverage
CIMPASI-1 and -2 show certolizumab pegol benefits patients with severe plaque psoriasis
ORLANDO – Results from two phase III trials indicated the tumor necrosis factor alpha inhibitor certolizumab pegol led to significant improvements...
From the Journals
Psoriasis and depression may pack a PsA punch
What role might depression play in development of psoriatic arthritis?
Feature
Humira Pen topped per-person drug spending in 2016
The spending top 10 includes three drugs for diabetes, two for arthritis/psoriasis, and two for multiple sclerosis.
News from the FDA/CDC
Brodalumab approved for psoriasis with REMS required
The FDA has approved brodalumab for treating moderate to severe psoriasis, with a REMS that addresses a risk of suicidal ideation and behavior...
From the Journals
Psoriatic arthritis raises diabetes risk
Psoriatic arthritis boosts the risk of diabetes, with higher disease activity magnifying that effect.
From the Journals
Subcutaneous high-dose methotrexate controls psoriasis
A little-studied route of methotrexate delivery produces rapid and sustained responses in moderate to severe psoriasis patients.
From the Journals
Perioperative infliximab does not increase serious infection risk
The timing of a last dose of infliximab prior to elective knee or hip replacement surgery does not appear to affect the 30-day risk of serious...
Peer to Peer
Psoriatic Arthritis Treatment: The Dermatologist’s Role
In this edition of the "Peer to Peer" audiocast series, Dr. Vincent DeLeo speaks with Dr. George Han about the dermatologist's role in treating...